Active	Status	Sponsor type	Region	Phase	Filter
1 Active 16 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stimuvax (tecemotide) / EMD Serono, Ono Pharma
ACTRN12607000173493: Cancer vaccine study for unresectable stage III non-small cell lung cancer	Recruiting	3	1322			Merck KGaA, Darmstadt, Germany, Merck KGaA,, EMD Pharmaceuticals Inc.	Non-small cell lung cancer (NSCLC) subjects with unresectable stage III disease